Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Probi AB (publ)
  6. News
  7. Summary
    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Probi : and Oriflame enter partnership for digestive...

06/15/2021 | 04:06am EDT
Press Release - 15 Jun 2021 Probi and Oriflame enter partnership for digestive probiotic concept launch

Two Swedish companies are teaming up in a partnership with focus on the Swedish heritage of innovation, natural ingredients and high-quality products. The probiotic supplier, Probi® and Oriflame have entered into agreement of a global launch of a probiotic supplement within general gut health.

The product contains a scientifically proven probiotic strain with documented health effects and is a customer specific formulation, based on Probi's concept called Probi Digestis®.

Hrvoje Rein, Global Senior Brand Manager of Wellness by Oriflame says: 'We are excited to be working with Probi, which is a true innovative probiotic supplier. A fruitful collaboration has made it possible to develop the first probiotic supplement in our product range, and our interactions have turned into an important partnership.'

'Wellness is one of Oriflame's strategic product categories that has generated the greatest value creation during the last years, from 8% sales in 2016 to 17% in 2020.With an extensive launch plan of our new probiotic supplement, we expect the Wellness category to grow even further,' Rein concludes.

Oriflame's extensive go-to-market plan covers a number of countries, with a wide geographic reach. First launch is planned to take place in Fall 2021 with a continued roll-out in the Wellness by Oriflame markets during 2022 and onwards.

'The partnership between Probi and Oriflame is an important step in our commercial efforts in offering clinically documented probiotic products to consumers all over the world. In our partnership with Oriflame we feel commitment and alignment in offering high quality products based upon research, clinical documentation and performance,'says Tom Rönnlund, CEO at Probi. For further information, please contact:

Tom Rönnlund, CEO, Probi®,
Phone: +46 46 286 89 40, E-mail: trd@probi.com

Charlotte Beyerholm, Director Marketing & Global Communication, Probi®,
Phone: +46 76 870 94 65, E-mail: charlotte.beyerholm@probi.com

ABOUT PROBI

Probi® is a global company focused exclusively on researching, manufacturing, and delivering probiotics for
supplements and functional food. We are experts at managing stable, live bacteria from R&D through every
stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics
available to people everywhere. Our health concepts, formulations, and formats are supported by robust clinical
documentation. Since our founding in 1991 at Sweden's Lund University, Probi has expanded its operations to
more than 40 markets. We hold more than 400 patents globally. Read more at www.probi.com.

Probi® is a registered trademark of Probi AB.

ABOUT ORIFLAME

Oriflame, founded in 1967, is a social selling beauty company in over 60 markets, with a diverse portfolio of Swedish, nature-inspired, innovative beauty and wellness products sold and marketed through approximately 3 million Oriflame Brand Partners.

PDF

Disclaimer

Probi AB published this content on 15 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 June 2021 08:05:02 UTC.


ę Publicnow 2021
All news about PROBI AB (PUBL)
08/31PROBI : Good tolerance in newborns of two specific probiotic...
PU
08/31PROBI : Good tolerance in newborns of two specific probiotic strains from Probi
AQ
08/31PROBI : Changes to Probi's Nomination Committee
PU
08/31PROBI : Changes to Probi's Nomination Committee
AQ
08/31Probi AB Announces Changes to Nomination Committee
CI
08/18SenzaGen appoints Peter Nählstedt as new CEO
AQ
07/16Probi Seeks Acquisitions
CI
07/16Q2 2021 : Probi enters new strategic partnerships
AQ
07/16Probi AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/13PROBI : Presentation of Probi's Q2 report 2021
PU
More news
Analyst Recommendations on PROBI AB (PUBL)
More recommendations
Financials
Sales 2021 712 M 81,9 M 81,9 M
Net income 2021 95,0 M 10,9 M 10,9 M
Net cash 2021 251 M 28,9 M 28,9 M
P/E ratio 2021 50,6x
Yield 2021 0,28%
Capitalization 4 843 M 560 M 557 M
EV / Sales 2021 6,45x
EV / Sales 2022 5,32x
Nbr of Employees -
Free-Float 35,6%
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 423,50 SEK
Average target price 505,00 SEK
Spread / Average Target 19,2%
EPS Revisions
Managers and Directors
Tom Juhani R÷nnlund Chief Executive Officer
Henrik Lundkvist Chief Financial Officer
Jean-Yves Parisot Chairman
Niklas Brandt Vice President-Information Technology
Niklas Larsson Lead Scientific Affairs
Sector and Competitors
1st jan.Capi. (M$)
PROBI AB (PUBL)-1.30%546
NESTLÉ S.A.9.96%341 295
MONDELEZ INTERNATIONAL, INC.2.99%84 177
YIHAI KERRY ARAWANA HOLDINGS CO., LTD-38.16%57 264
DANONE10.73%45 398
THE KRAFT HEINZ COMPANY3.69%43 969